Will health insurance cover Eteplirsen?

Health insurance coverage for Eteplirsen may vary depending on the specific insurance plan. It is recommended to contact your insurance provider to determine if Eteplirsen is covered under your policy.

Eteplirsen is a medication used for the treatment of Duchenne muscular dystrophy (DMD) in individuals who have a specific gene mutation. It helps in the production of a protein called dystrophin, which is essential for muscle function.

Eteplirsen works by skipping a specific section of genetic code called exon 51, allowing the production of a shortened but partially functional form of dystrophin. This can help slow down the progression of DMD and improve muscle strength.

Yes, Eteplirsen received accelerated approval from the U.S. Food and Drug Administration (FDA) in 2016 for the treatment of DMD in patients with a confirmed mutation of the dystrophin gene amenable to exon 51 skipping.

Common side effects of Eteplirsen may include balance disorder, vomiting, contact dermatitis, and cough. It is important to consult with a healthcare professional for a complete list of possible side effects and to discuss any concerns.

No, Eteplirsen is not a cure for Duchenne muscular dystrophy. It is a treatment that can help slow down the progression of the disease and improve muscle strength in individuals with specific gene mutations.